Bart van Velzen
Articles
Tetraphase: A Bidding War Shareholders Shouldn't Wait Around For
Novelion Therapeutics: 25% Sale Ends Thursday
Anixter: Why I Believe Wesco Will Bump Its Bid
Fiat Chrysler: Doing The Numbers On The Merger Spread With PSA
NII Holdings: Final Boarding Call For This Liquidation Play
Realm Therapeutics: A Cash Grab In Progress
Eco Science Solutions: It's All Just A Little Bit Of History Repeating
Cannabis Sativa: All Hype
MGT Capital: Dilution Ahead
Paragon Shipping: Why Its Share Price Spiked, And Why It Will Fall
Eleven Biotherapeutics: No Immediate Pipeline And Running Out Of Cash; 70% Downside.
DARA Biosciences: An Attractive Short Term Merger Play
KaloBios: Martin Shkreli Vs. The Rest Of The World
AgriEuro Corporation: A Stock Promotion That Will Likely End In Disaster
The Titanic Ten: Exposing 10 Related OTC Stocks
Joymain International Development Group: My Take On This Tiny Company Worth $6B
Green Technology Solutions: Throwing Shareholders Under The Bus Again And Again
Interactive Multi-Media Auction: A Pump-And-Dump In Full Swing
Valmie Resources: Two Guys, One Drone And A 150M Market Cap